The Dry Eye Syndrome Treatment Market was valued at USD 5.86 billion in 2023 and is poised for significant expansion, with projections indicating a growth to USD 10.17 billion by 2032 at a robust CAGR of 6.32%. This remarkable growth is driven by a surge in the prevalence of dry eye syndrome globally, coupled with technological advancements and evolving...